The synergic relationship between Escherichia coli and Bacteroides fragilis was examined in a model of intra-abdominal abscess formation. The addition of B. fragilis to E. coli in the fibrin clot inoculum increased abscess weight and residual numbers of E. coli in the abscess at 7 days. In a reciprocal fashion, E. coli was capable of enhancing B. fragilis persistence in abscesses. Neither heat-killed E. coli nor heat-killed B. fragilis was able to mimic the synergic effect of its live counterpart. Furthermore, B. fragilis culture filtrate was unable to reproduce the ability of live B. fragilis to act synergically with E. coli. For B. fragilis to act synergically with E. coli, it had to be inoculated locally with E. coli in the peritoneal cavity, indicating that an effect on systemic resistance by B. fragilis was an unlikely mechanism for the production of bacterial synergy. These studies suggest that the synergic relationship between bacteria in polymicrobial infections is a complex one, resulting from intimate interactions between bacteria and the host in the local milieu of the infection.
BerneT. V.,
YellinA. W.,
ApplemanM. D.,
HeseltineP. N. R.1982; Antibiotic management of surgically treated gangrenous or perforated appendicitis:comparison of gentamicin and clindamycin versus cefamandole versus cefoperazone. American Journal of Surgery 144:8–13
BrookI.,
HunterV.,
WalkerR. I.1984; Synergistic effect of Bacteroides, Clostridium, Fusobacterium, anaerobic cocci, and aerobic bacteria on mortality and induction of subcutaneous abscesses in mice. Journal of Infectious Diseases 149:924–928
DunnD. L.,
BarkeR. A.,
EwaldD. C.,
SimmonsR. L.1985; Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses. Infection and Immunity 48:287–291
DunnD. L.,
BarkeR. A.,
EwaldD. C.,
SimmonsR. L.1987; Macrophages and translymphatic absorption represent the first line of host defense of the peritoneal cavity. Archives of Surgery 122:105–110
HagenJ. C.,
WoodW. S.,
HashimotoT.1983; Experimental intraabdominal abscess formation by Escherichia coli and Bacteroidesfragilis. European Journal of Clinical Microbiology 2:43–49
HiteK. E.,
LockeM.,
HesseltineH. C.1949; Synergism in experimental infection with nonsporulating ahaerobic bacteria. Journal of Infectious Diseases 84:1–9
HoldemanL. V.,
CatoE. P.,
MooreW. E. C.1977; Anaerobe Laboratory Manual. 4th edn Anaerobe Laboratory; Virginia Polytechnic Institute and State University, Blacksburg, VA:
InghamH. R.,
SissonP. R.,
MiddletonR. L.,
NarangH. K.,
CoddA. A.,
SelkonJ. B.1981; Phagocytosis and killing of bacteria in aerobic and anaerobic conditions. Journal of Medical Microbiology 14:391–399
JonesG. R.,
GemmellC. G.1982; Impairment by Bacteroides species of opsonization and phagocytosis of enterobacteria. Journal of Medical Microbiology 15:351–361
KellyM. J.1978; The quantitative and histological demonstration of pathogenic synergy between Escherichia coli and Bacteroides fragilis in guinea-pig wounds. Journal of Medical Microbiology 11:513–523
MacLarenD. M.,
NamavarF.,
Verweij-van VughtA. M. J. J.,
VelW. A. C.,
KaanJ. A.1984; Pathogenic synergy:mixed intraabdominal infections. Antonie van Leeuwenhoek 50:775–787
NamavarF.,
VerweijA. M. J. J.,
BalM.,
van SteenbergenT. J.,
de GraafJ.,
MacLarenD. M.1983; Effect of anerobic bacteria on killing of Proteus mirabilis by human polymorphonuclear leukocytes. Infection and Immunity 40:930–935
OnderdonkA. B.,
KasperD. L.,
CisnerosR. L.,
BartlettJ. B.1977; The capsular polysaccharide of Bacteroides fragilis as a virulence factor:comparison of the pathogenic potential of encapsulated and unencapsulated strains. Journal of Infectious Diseases 136:82–89
ReznikovM.,
Finlay-JonesJ. J.,
McDonaldP. J.1981; Effect of Bacteriodesfragilis on the peritoneal clearance of Escherichia coli in mice. Infection and Immunity 32:398–399
RodloffA. C.,
BeckerJ.,
BlanchardD. K.,
KleinT. W.,
HahnH.,
FreidmanH.1986; Inhibition of macrophage phagocytosis by Bacteroides fragilis in vivo and in vitro. Infection and Immunity 52:488–492
RotsteinO. D.,
KaoJ.1988; The spectrum of Escherichia coli-Bacteroides fragilis pathogenic synergy in an intraabdominal infection model. Canadian Journal of Microbiology 34:352–357
RotsteinO. D.,
PruettT. L.,
SimmonsR. L.1985; Lethal microbial synergism in intra-abdominal infections:Escherichia coli and Bacteroides fragilis. Archives of Surgery 120:146–151
RotsteinO. D.,
PruettT. L.,
SorensonJ. J.,
FiegelV. D.,
NelsonR. D.,
SimmonsR. L.1986; A Bacteroides by-product inhibits human polymorphonuclear leukocyte function. Archives of Surgery 121:82–88
RotsteinO. D.,
PruettT. L.,
WellsC. L.,
SimmonsR. L.1987; The role of bacteroides encapsulation in the lethal synergy between Escherichia coli and Bacteroides species in a rat fibrin clot peritonitis model. Journal of Infection 15:135–146
ShapiroM. E.,
KasperD. L.,
ZaleznikD. F.,
SpriggsS.,
OnderdonkA. B.,
FinbergR. W.1986; Cellular control of abscess formation:role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis. Journal of Immunology 137:341–346
ShapiroM. E.,
OnderdonkA. B.,
KasperD. L.,
FinbergR. W.1982; Cellular immunity to Bacteroides fragilis capsular polysaccharide. Journal of Experimental Medicine 155:1188–1197
Van DykeT. E.,
BartholemewE.,
GencoR. J.,
SlotsJ.,
LevineM. J.1982; Inhibition of neutrophil chemotaxis by soluble bacterial products. Journal of Periodontology 53:502–508
Verweij-van VughtA. M. J. J.,
NamavarF.,
SparriusM.,
VelW. A. C.,
MacLarenD. M.1985; Pathogenic synergy between Escherichia coli and Bacteroides fragilis: studies in an experimental mouse model. Journal of Medical Microbiology 19:325–331
WellsC. L.,
ArlandL. A.,
SimmonsR. L.,
RotsteinO. D.1985; In vivo bactericidal activity of Sch 34343 in Bacteroides fragilis abscesses and in Bacteroides fragilis-Escherichia coli abscesses. Journal of Antimicrobial Chemotherapy 15: Suppl C199–206